Product Images Cyclophosphamide

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Cyclophosphamide NDC 10019-938 by Baxter Healthcare Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Cyclophosphamide Structural Formula - image 01

Cyclophosphamide Structural Formula - image 01

Representative Cyclophosphamide NovaPlus container label NDC 10019-938-25 - image 02

Representative Cyclophosphamide NovaPlus container label NDC 10019-938-25 - image 02

This is the label of Cyclophosphamide, a cytotoxic agent for single dose use only, manufactured by Baer Healthcare Corporation. Each vial contains 500mg of the drug which can be dissolved in either sterile water or 0% Sodium Chloride Injection depending on the mode of administration. The drug is indicated for IV infusion and direct injection only. The label contains more information on dosage and storage instructions.*

Cyclophosphamide NovaPlus Representative carton label panel 1 NDC 10019-938-01 - image 03

Cyclophosphamide NovaPlus Representative carton label panel 1 NDC 10019-938-01 - image 03

This is a medication that contains 500 mg cyclophosphamide. The medication comes in a single-dose vial marked HA-80-02.219 and must be diluted before use for IV infusion or direct injection. For IV infusion, 25 mL of Sterile Water for Injection, USP, should be added and for direct injection, 25 mL of 3% Sodium Chloride Injection, USP should be added. The vial should be stored at or below 25°C. The proper dosage and usage should be determined by a healthcare professional with a thorough knowledge of the medication. This medication is a cytotoxic agent for single-dose use and is sterile and non-pyrogenic. Manufactured by Banar Haahhcars Corporation in the USA, and has registered trademarks of N and NOVAPLUS.*

Cyclophosphamide NovaPlus Representative carton label panel 2 NDC 10019-938-01 - image 04

Cyclophosphamide NovaPlus Representative carton label panel 2 NDC 10019-938-01 - image 04

This is a description of a medication called Ronly, which must be diluted for IV infusion or direct injection use. It comes in a single dose vial manufactured by Baxter Healthcare Corporation in Deerfield, Illinois, USA. Both the N and NOVAPLUS names are registered trademarks of Vizn, Inc. The medication is made in Germany.*

Cyclophosphamide NovaPlus Representative Container NDC 10019-939-50 - image 05

Cyclophosphamide NovaPlus Representative Container NDC 10019-939-50 - image 05

This is a description of a drug called Cyclophosphamide that comes in injection form for single use only. It is a cytotoxic agent and should be used for parenteral purposes only. It is sterile and non-pyrogenic. It is manufactured by Baxter Healthcare Corporation in Doarfel, USA, and made in Germany. Each vial contains 1g of Cyclophosphamide. To use for IV infusion, one should add 50 ml of sterile water and shake vigorously to dissolve the drug. For direct injection, 50 ml of 0.9% Sodium Chloride Injection should be added and shaken vigorously to dissolve it. More information on indications and dosage can be found in the insert provided. It should be stored at or below 25°C (77°F) in a controlled room.*

Cyclophosphamide NovaPlus Representative Carton Label 10019-939-01 1 of 2 - image 06

Cyclophosphamide NovaPlus Representative Carton Label 10019-939-01  1 of 2 - image 06

This is a medication called cyclophesphanide manufactured by Baxter Health Care Corporation and used for intravenous infusion or direct injection. The dosage and instructions for use are not provided, and it must be diluted before use. Made in Germany.*

Cyclophosphamide NovaPlus Representative Carton Label 10019-939-01 2 of 2 - image 07

Cyclophosphamide NovaPlus Representative Carton Label 10019-939-01  2 of 2 - image 07

This is a description of a medication called "Reonly" manufactured by Baxter Healthcare Corporation. It can be used for IV infusion or direct injection but must be diluted first. The medication comes in a single-dose vial and the product is registered under the trademarks "NOVAPLUS" and "Baxter Healthcare Corporation". The product is manufactured in Germany.*

Cyclophosphamide NovaPlus Representative Container Label 10019-942-10 - image 08

Cyclophosphamide NovaPlus Representative Container Label 10019-942-10 - image 08

This is a description of a medication called Cyclophosphamide for Injection, which is a cytotoxic agent used for single dose treatment through parental use. It is sterilized and non-pyrogenic, manufactured by Baer HealthCare Corporation in Germany. The medication comes in a vial containing 2g of Cyclophosphamide, which can be administered through IV infusion or direct injection with the addition of Sterile Water for Injection or 0% Sodium Chloride Injection, respectively. The required indications and dosage schedule can be found in the insert of the medication. The vial must be stored at or below 25°C (77°F) as specified by USP Controlled Room Temperature.*

Cyclophosphamide NovaPlus Representative Carton Label 10019-942-01 1 of 2 - image 09

Cyclophosphamide NovaPlus Representative Carton Label 10019-942-01   1 of 2 - image 09

This is information about a drug called cyclophosphamide. The drug is sold in a vial with the code HA-80.02.221 and is intended for intravenous infusion or direct injection use. To dissolve the drug in IV infusion, 100 mL of sterile water for injection, USP should be added, while for direct injection, 100 mL of 0% sodium chloride injection, USP is required. The drug should be stored at a temperature of 2-25°C. There are instructions for dosage included in the package insert, and it is emphasized that the drug should not be administered without proper knowledge of dose, indications, and toxicity. Finally, the drug is a cytotoxic agent and is sterile and non-pyrogenic for single use only. The manufacturer is Baxter Healthcare Corporation, which is located in Deerfield, IL, USA. The text also mentions that "NOVAPLUS" is a registered trademark of V.A. and is based in Wadain, Germany.*

Cyclophosphamide NovaPlus Representative Carton Label 10019-942-01 2 of 2 - image 10

Cyclophosphamide NovaPlus Representative Carton Label 10019-942-01   2 of 2 - image 10

This text is a warning that the product "Roonly" needs to be diluted before being administered through IV infusion or direct injection. It is a single-dose vial manufactured in the USA by Baxter Healthcare Corporation. It also mentions the registered trademarks N and Novaplus of Vizint, Inc. and that it was made in Germany.*

Cyclophosphamide Representative Label 10019-938-01 1 of 2 - image 11

Cyclophosphamide Representative Label 10019-938-01 1 of 2 - image 11

This is a description of a medicine called Cyclophosphamide for Injection, USP 500 mg, produced by Baxter Healthcare Corporation, in the USA. It comes in a package of 120 packs, each containing one single-dose vial of 500mg. The medicine should be stored at or below 25°C (77°F). It also provides the INDC number and an expiration date.*

Cyclophosphamide Representative Label 10019-938-01 2 of 2 - image 12

Cyclophosphamide Representative Label 10019-938-01 2 of 2 - image 12

NOVAPLUS' Cyclophosphamide for Injection is a medication that contains 500 mg that should be stored at or below 25°C (77°F). It comes in packs of 120, and each pack contains a 500 mg single-dose vial. The medication is manufactured by Baxter Healthcare Corporation, and it has an expiration date of MMM JJJJ and a lot number of JMXXXA. The quantity is 00. There are some additional codes on the packaging, but they are not useful for describing the medication.*

Cyclophosphamide Representative Label 10019-939-01 1 of 2 - image 13

Cyclophosphamide Representative Label 10019-939-01 1 of 2 - image 13

This is a description of the drug Cyclophosphamide for Injection. It comes in single dose vials containing 1 gram and should be stored at or below 25°C (77°F). The drug is manufactured by Baxter Healthcare Corporation located in Deerfed, Illinois, USA. The lot number is JMXXXA and the drug may be sold in packs of 120 units. The drug is branded as NOVAPLUS and N+. There is also additional numbering on the page, but it does not correspond to a description of the drug.*

Cyclophosphamide Representative Label 10019-939-01 2 of 2 - image 14

Cyclophosphamide Representative Label 10019-939-01 2 of 2 - image 14

Cyclophosphamide Representative Label 10019-942-01 1 of 2 - image 15

Cyclophosphamide Representative Label 10019-942-01 1 of 2 - image 15

This is a description of a medical product called "Cyclophosphamide for Injection" which is stored below 25°C (77°F). It is produced by Baxter Healthcare Corporation, and includes 60 packs, each containing a single dose of 2g. The product has an INDC of 10019-942-01, and a lot number of JMXXXA. The text also includes details about the product's expiration date, trademark information for NOVAPLUS, and a series of numerical codes which may be related to its identification or production.*

Cyclophosphamide Representative Label 10019-942-01 2 of 2 - image 16

Cyclophosphamide Representative Label 10019-942-01 2 of 2 - image 16

NOVAPLUS’ Cyclophosphamide for Injection is a medication available in packs of 60 single-dose vials, each containing 2 g of USP. It is manufactured by Baxter Healthcare Corporation and must be stored at or below 25°C (77°F). The product is registered under trademarks of Vizent, Inc. The batch code for the product is JMXXXA with an expiration date of MMM JJJJ, and a quantity of 00.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.